Both in Pharmaceuticals
Structure Therapeutics vs Amarin
Over the past year GPCR returned −40.0% and AMRN returned −26.8%; their daily moves had a correlation of -0.06.
GPCR −40.0% AMRN −26.8%Growth of $1, one year, split-adjusted
| Metric | GPCR | AMRN |
|---|---|---|
| Price | $20.35 | $11.61 |
| Market cap | $1.45B | $488.1M |
| Today | +6.66% | +0.30% |
| 1 month | −20.7% | −3.2% |
| 6 months | −48.0% | −22.9% |
| Year to date | −70.7% | −16.8% |
| 1 year | −36.8% | −24.2% |
| Revenue growth (YoY) | — | −20.4% |
| Gross margin | — | 40.9% |
| Net margin | — | 0.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.8× |
| Net cash | $1.34B | $323.4M |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 31.0% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).